ORNA

Orna Therapeutics, Inc.

Application Filed: 2020-03-09
Trademark Application Details
Trademark Logo ORNA

Mark For: ORNA™ trademark registration is intended to cover the categories of pharmaceuticals for the treatment of cancer, autoimmune, immune mediated, and inflammatory diseases and disorders, a full line of nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics. [all]

Status

2021-06-24 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number88827351
Mark Literal ElementsORNA
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK. SERVICE MARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2020-09-01
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameJessica L. Rothstein
Attorney Docket Number141736297050

Timeline

2020-03-09Application Filed
2020-03-12Location: NEW APPLICATION PROCESSING
2020-03-12Status: Live/Pending
2020-03-12Transaction Date
2020-07-07Published
2020-09-01Location: INTENT TO USE SECTION
2021-03-12Status: A first request for extension of time to file a Statement of Use has been granted.

Trademark Parties (Applicants & Owners)

Party: ORNA THERAPEUTICS, INC.
Address620 Memorial Drive Cambridge, MASSACHUSETTS UNITED STATES 02139
Legal Entity TypeCorporation
Legal Entity StateDELAWARE
Party: Oroboros, Inc.
Address450 Kendall Street Cambridge, MASSACHUSETTS UNITED STATES 02142
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

*multiple parties listed, check assignment documents for ownership information

Documents

ApplicationMULTI2020-03-09
DrawingJPEG2020-03-09
XSearch Search SummaryXML2020-05-28
TRAM Snapshot of App at Pub for OppostnMULTI2020-05-29
Notice of PublicationXML2020-06-17
Notification Of Notice of PublicationXML2020-06-17
OG Publication ConfirmationAPPLICATION/XML2020-07-07
Notice of AllowanceAPPLICATION/XML2020-09-01
Extension of Time to File SOUMULTI2021-02-23
ITU Extension ApprovalAPPLICATION/XML2021-03-13
ITU Unit ActionMULTI2021-03-13
Change Address or Representation FormXML2021-04-15

Attorney of Record

JESSICA L. ROTHSTEIN
GOODWIN PROCTER LLP
620 EIGHTH AVENUE
NEW YORK, NY 10018

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: Pharmaceuticals for the treatment of cancer, autoimmune, immune mediated, and inflammatory diseases and disorders, a full line of nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics
IC 042. US 100 101. G & S: Scientific research in the fields of nucleic acid pharmaceuticals, medicine, biologics, biotherapeutics, biosimilars and therapeutics

International Codes:5
U.S. Codes:006,018,044,046,051,052
International Codes:42
U.S. Codes:100,101
Type CodeType
GS0051Pharmaceuticals for the treatment of cancer, autoimmune, immune mediated, and inflammatory diseases and disorders, a full line of nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics
GS0051Pharmaceuticals for the treatment of cancer, autoimmune, immune mediated, and inflammatory diseases and disorders; nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars, and therapeutics for the treatment of cancer, autoimmune, immune mediated, immune system related, and inflammatory diseases and disorders; nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars, and therapeutics for the prevention and treatment of viral and infectious diseases; nucleic acid pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars, and therapeutics for therapeutic vaccines

Assignments

Trademark Filing History

DescriptionDateProceeding Number
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2021-04-15
TEAS CHANGE OF OWNER ADDRESS RECEIVED2021-04-15
TEAS CHANGE OF CORRESPONDENCE RECEIVED2021-04-15
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2021-04-15
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2021-04-1588888
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2021-03-13
EXTENSION 1 GRANTED2021-03-1270565
CASE ASSIGNED TO INTENT TO USE PARALEGAL2021-03-1070565
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP2021-02-24
TEAS EXTENSION RECEIVED2021-02-23
EXTENSION 1 FILED2021-02-2370565
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2020-09-01
PUBLISHED FOR OPPOSITION2020-07-07
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2020-07-07
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2020-06-17
ASSIGNED TO EXAMINER2020-05-2873359
APPROVED FOR PUB - PRINCIPAL REGISTER2020-05-28
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2020-03-14
NEW APPLICATION ENTERED IN TRAM2020-03-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed